Informative censoring — a neglected cause of bias in oncology trials
Sign Up to like & getrecommendations! Published in 2020 at "Nature Reviews Clinical Oncology"
DOI: 10.1038/s41571-020-0368-0
Abstract: Informative censoring occurs when progression-free survival is the primary end point of a randomized clinical trial and unequal patient dropout is observed between treatment arms owing to poorer tolerance of experimental treatment. Herein we discuss… read more here.
Keywords: cause bias; informative censoring; censoring neglected; neglected cause ... See more keywords